Teva and MedinCell Announce FDA Acceptance of New Drug Appli

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , France , Israel , Hafrun Fridriksdottir , Christophe Douat , Yael Ashman , Medincell Euronext , Yonatan Beker , Kevinc Mannix , David Heuz , Doris Li , Drug Administration , Teva Pharmaceuticals , Teva Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries , New Drug Application , Risperidone Subcutaneous Extended Release Study , Maintenance Treatment , Executive Vice President , Pharmaceutical Industries , Private Securities Litigation Reform Act , Annual Report , Newcap Media Relation ,